Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

Cramer Weighs In On Canopy Growth, Dish Network And More

On CNBCs "Mad Money Lightning Round," Jim Cramer said the negative commentary about Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is wrong. read…

Vertex Pharmaceuticals: Upgrade

Milwaukee (www.aktiencheck.de) - Rating-Update: Brian P. Skorney, Analyst von Robert W. Baird, stuft die Aktie des US-Biotechkonzerns Vertex Pharmaceuticals Inc. (ISIN:…

Vertex Pharmaceuticals: Hochstufung und neues Kursziel

Milwaukee (www.aktiencheck.de) - Rating-Update: Brian Skorney, Analyst von Robert W. Baird, stuft die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

10 Biggest Price Target Changes For Tuesday

Baird boosted Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $220 to $252. Vertex Pharmaceuticals shares rose 0.6% to…

What Should Vertex Pharmaceuticals Buy With its $6.6 Billion Stash?

The biotech is looking for late-sage drugs to fuel future growth....…

Insiderhandel: EVP, Chief Commercial Officer verkauft Aktien von Vertex Pharmaceuticals im Wert von 332.146 $

Arbuckle, Stuart A. - Vorstand - Tag der Transaktion: 2021-02-03...…

Insiderhandel: EVP, Chief Adm, Leg & BD Off verkauft Aktien von Vertex Pharmaceuticals im Wert von 86.624 $

Parini, Michael - Vorstand - Tag der Transaktion: 2021-02-03...…

Vertex Pharmaceuticals Poised For Long-Term Growth

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Vertex Pharmaceuticals Stock Fell Today

Investors were not pleased with the companys latest quarterly update....…

Uber, UPS rise; Vertex Pharmaceuticals, BP fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:...…

Vertex (VRTX) Q4 Earnings Miss, Revenues Beat Estimates

Vertex (VRTX) reports missing earnings estimates in the fourth quarter of 2020, while revenues surpass the same. The company provides…

Vertex CEO says company is seeking to make transformative deals

Shares of Vertex Pharmaceuticals Inc. were down 4.3% in trading on Tuesday, the day after the company discussed its…

Vertex Pharmaceuticals Incorporated 2020 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex Pharmaceuticals Inc (VRTX) Q4 2020 Earnings Call Transcript

VRTX earnings call for the period ending December 31, 2020....…

Vertex Pharmaceuticals Incorporated (VRTX) CEO Dr. Reshma Kewalramani on Q4 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex Pharmaceuticals (VRTX) Lags Q4 Earnings Estimates

Vertex (VRTX) delivered earnings and revenue surprises of -5.28% and 2.91%, respectively, for the quarter ended December 2020. Do the…

Vertex Pharmaceuticals: Q4 Earnings Insights

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) fell 1.1% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose…

VERTEX PHARMACEUTICALS INC / MA: 8-K Report

8-K...…

Vertex Pharmaceuticals EPS misses by $0.06, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks.com featured highlights include: Crocs, AGCO, Meritage Homes and Vertex Pharmaceuticals

Zacks.com featured highlights include: Crocs, AGCO, Meritage Homes and Vertex Pharmaceuticals...…

Vertex Pharmaceuticals Q4 2020 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Earnings Preview for Vertex Pharmaceuticals

Vertex Pharmaceuticals (NASDAQ:VRTX) unveils its next round of earnings this Monday, February 01. Get prepared with Benzingas ultimate preview for…

Why Earnings Season Could Be Great for Vertex (VRTX)

Vertex (VRTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

The Zacks Analyst Blog Highlights: NIKE, Amgen, Morgan Stanley, Vertex Pharma and Moderna

The Zacks Analyst Blog Highlights: NIKE, Amgen, Morgan Stanley, Vertex Pharma and Moderna...…

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $241.31, moving +1.57% from the previous trading session....…

Vertex Pharmaceuticals: A Play On Market Overreaction

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why the Earnings Surprise Streak Could Continue for Vertex (VRTX)

Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Vertex Pharmaceuticals (VRTX) Stock Moves -0.25%: What You Should Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $225.55, marking a -0.25% move from the previous day....…

Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition

ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Nov. 04, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) and…